Edward S Harkness Eye Institute, Columbia University Medical Center, New York, NY 10032, USA.
Br J Ophthalmol. 2010 Nov;94(11):1483-9. doi: 10.1136/bjo.2009.167270. Epub 2010 Sep 9.
To describe the treatment of macular oedema secondary to branch retinal vein occlusion (BRVO) with concomitant pars plana vitrectomy/arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide.
Retrospective case series.
Four eyes of four patients were identified. Patients improved from a mean best-corrected visual acuity of 20/124 at baseline to 20/122 at month 1, 20/83 at month 3, 20/74 at month 6, 20/59 at month 9 and 20/44 at month 12 (p = 0.01). All patients demonstrated improvement in visual acuity and macular oedema on fluorescein angiography and/or optical coherence tomography (OCT).
For patients with persistent macular oedema due to BRVO refractory to pharmacotherapy and/or laser photocoagulation, concomitant pars plana vitrectomy with arteriovenous sheathotomy and intravitreal triamcinolone may improve best-corrected acuity and reduce macular oedema on fluorescein angiography and OCT.
描述玻璃体内曲安奈德注射联合视网膜静脉分支阻塞(BRVO)患眼玻璃体切除术/动静脉鞘切开术治疗黄斑水肿的效果。
回顾性病例系列研究。
4 名患者的 4 只眼纳入研究。患者最佳矫正视力从基线时的 20/124 提高到 1 个月时的 20/122、3 个月时的 20/83、6 个月时的 20/74、9 个月时的 20/59 和 12 个月时的 20/44(p = 0.01)。所有患者的视力和黄斑水肿均在荧光素眼底血管造影和/或光学相干断层扫描(OCT)上得到改善。
对于药物治疗和/或激光光凝治疗抵抗的 BRVO 导致的持续性黄斑水肿患者,玻璃体内曲安奈德注射联合视网膜静脉分支阻塞患眼玻璃体切除术/动静脉鞘切开术可能提高最佳矫正视力,并减少荧光素眼底血管造影和 OCT 上的黄斑水肿。